Angi Inc
F:2UH
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
9.795
18.43
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
2UH
stock under the Base Case scenario is
46.12
EUR.
Compared to the current market price of 14.14 EUR,
Angi Inc
is
Undervalued by 69%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Angi Inc.
| US |
|
Alphabet Inc
NASDAQ:GOOGL
|
|
| US |
|
Meta Platforms Inc
NASDAQ:META
|
|
| CN |
|
Tencent Holdings Ltd
HKEX:700
|
|
| CN |
|
Baidu Inc
NASDAQ:BIDU
|
|
| JP |
L
|
LY Corp
XMUN:YOJ
|
|
| CN |
|
Kuaishou Technology
HKEX:1024
|
|
| KR |
|
Naver Corp
KRX:035420
|
|
| NL |
|
Nebius Group NV
NASDAQ:NBIS
|
|
| JP |
|
Z Holdings Corp
TSE:4689
|
|
| KR |
|
Kakao Corp
KRX:035720
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Angi Inc
Balance Sheet Decomposition
Angi Inc
| Current Assets | 407.4m |
| Cash & Short-Term Investments | 340.7m |
| Receivables | 38.4m |
| Other Current Assets | 28.3m |
| Non-Current Assets | 1.3B |
| PP&E | 93.1m |
| Intangibles | 1.1B |
| Other Non-Current Assets | 188.4m |
| Current Liabilities | 215.2m |
| Accounts Payable | 38.9m |
| Accrued Liabilities | 146.4m |
| Other Current Liabilities | 29.9m |
| Non-Current Liabilities | 538.1m |
| Long-Term Debt | 497.5m |
| Other Non-Current Liabilities | 40.6m |
Free Cash Flow Analysis
Angi Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Angi Inc
|
Revenue
|
1.1B
USD
|
|
Cost of Revenue
|
-54.8m
USD
|
|
Gross Profit
|
1B
USD
|
|
Operating Expenses
|
-941.2m
USD
|
|
Operating Income
|
61.6m
USD
|
|
Other Expenses
|
-26.3m
USD
|
|
Net Income
|
35.3m
USD
|
2UH Profitability Score
Profitability Due Diligence
Angi Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Score
Angi Inc's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
2UH Solvency Score
Solvency Due Diligence
Angi Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Score
Angi Inc's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
2UH Price Targets Summary
Angi Inc
According to Wall Street analysts, the average 1-year price target for
2UH
is 21.83 EUR
with a low forecast of 14.6 EUR and a high forecast of 31.51 EUR.
Dividends
Current shareholder yield for
ANGI is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
2UH
stock under the Base Case scenario is
46.12
EUR.
Compared to the current market price of 14.14 EUR,
Angi Inc
is
Undervalued by 69%.